Nella sua revisione, il PRAC ha considerato anche i dati sullefficacia dei medicinali contenenti 17-OHPC nei loro usi autorizzati, compresi i risultati di uno studio che esaminava lefficacia nella prevenzione del parto pretermine
While microdosing is a common, colloquially-used term, specifics on reduced frequency and/or dosing after initial weight loss is still emerging. The Bottom Line on Microdosing GLP-1s Research on GLP-1s for weight loss is, overall, promising
Isso no significa que o produto tenha a mesma ao de um medicamento agonista de GLP-1
Moreover, the relationship between UA levels and MS-related disability suggests that UA could be a good biomarker of MS disability and progression [159, 160]
Inclusion criteria for the patients in this study included age between 18 and 65 years and a diagnosis of primary polydipsia based on polydipsia of greater than 3000 mL per day and polyuria of greater than 50 mL/kg body weight per day